Maturation of pluripotent stem cell-derived cardiomyocytes: limitations and challenges from metabolic aspects

Maturation of pluripotent stem cell-derived cardiomyocytes: limitations and challenges from metabolic aspects

Abstract Acute coronary syndromes, such as myocardial infarction (MI), lack effective therapies beyond heart transplantation, which is often hindered by donor scarcity and postoperative complications. Human induced pluripotent stem cells (hiPSCs) offer the possibility of myocardial regeneration by d...

Descripció completa

Dades bibliogràfiques
Autors principals:	Xi Jiang, Xin Lian, Kun Wei, Jie Zhang, Kaihua Yu, Haoming Li, Haichun Ma, Yin Cai, Lei Pang
Format:	Article
Idioma:	English
Publicat:	BMC 2024-10-01
Col·lecció:	Stem Cell Research & Therapy
Matèries:	Acute coronary syndromes Myocardial infarction Induced pluripotent stem cells iPSC-cardiomyocytes Maturation Energy metabolism
Accés en línia:	https://doi.org/10.1186/s13287-024-03961-4

Ítems similars

Maturation of induced pluripotent stem cell-derived cardiomyocytes and its therapeutic effect on myocardial infarction in mouse
per: Peng Wu, et al.
Publicat: (2023-02-01)

Characterization of cardiac metabolism in iPSC-derived cardiomyocytes: lessons from maturation and disease modeling
per: Sofija Vučković, et al.
Publicat: (2022-07-01)

iPSC-Derived Cardiomyocytes in Inherited Cardiac Arrhythmias: Pathomechanistic Discovery and Drug Development
per: Eline Simons, et al.
Publicat: (2023-01-01)

Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells
per: Jiangtao Li, et al.
Publicat: (2022-06-01)

Metabolic Maturation Exaggerates Abnormal Calcium Handling in a <i>Lamp2</i> Knockout Human Pluripotent Stem Cell-Derived Cardiomyocyte Model of Danon Disease
per: Robert J. Barndt, et al.
Publicat: (2022-12-01)

Disease Modeling of Mitochondrial Cardiomyopathy Using Patient-Specific Induced Pluripotent Stem Cells
per: Takeshi Tokuyama, et al.
Publicat: (2021-09-01)

Deep learning detects cardiotoxicity in a high-content screen with induced pluripotent stem cell-derived cardiomyocytes
per: Francis Grafton, et al.
Publicat: (2021-08-01)

Cardiac repair in a murine model of myocardial infarction with human induced pluripotent stem cell-derived cardiomyocytes
per: Xin Jiang, et al.
Publicat: (2020-07-01)

Activation of AMPK Promotes Maturation of Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
per: Liang Ye, et al.
Publicat: (2021-03-01)

Action potential variability in human pluripotent stem cell-derived cardiomyocytes obtained from healthy donors
per: A. B. Carvalho, et al.
Publicat: (2022-12-01)

The role and mechanism of NRG1/ErbB4 in inducing the differentiation of induced pluripotent stem cells into cardiomyocytes
per: Xiaoou Li, et al.
Publicat: (2024-10-01)

Strategies to improve the therapeutic effect of pluripotent stem cell-derived cardiomyocytes on myocardial infarction
per: Yang Xiao, et al.
Publicat: (2022-08-01)

Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes
per: Jingjun Zhou, et al.
Publicat: (2023-04-01)

Qualitative transcriptional signatures for evaluating the maturity degree of pluripotent stem cell-derived cardiomyocytes
per: Rou Chen, et al.
Publicat: (2019-03-01)

Immune cells and RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges
per: Jin-he Jiang, et al.
Publicat: (2024-01-01)

Impaired Relaxation in Induced Pluripotent Stem Cell‐Derived Cardiomyocytes with Pathogenic TNNI3 Mutation of Pediatric Restrictive Cardiomyopathy
per: Renjie Wang, et al.
Publicat: (2024-03-01)

Rock inhibitor may compromise human induced pluripotent stem cells for cardiac differentiation in 3D
per: Bin Jiang, et al.
Publicat: (2022-03-01)

In vitro maturation of human pluripotent stem cell-derived cardiomyocyte: A promising approach for cell therapy
per: Yun-Gwi Park, et al.
Publicat: (2022-06-01)

In Vivo Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Neonatal and Adult Rat Hearts
per: Shin Kadota, et al.
Publicat: (2017-02-01)

Unlocking the Pragmatic Potential of Regenerative Therapies in Heart Failure with Next-Generation Treatments
per: Yoshikazu Kishino, et al.
Publicat: (2023-03-01)

Fatty Acid-Treated Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes Exhibit Adult Cardiomyocyte-Like Energy Metabolism Phenotypes
per: Yuichi Horikoshi, et al.
Publicat: (2019-09-01)

ELM2‐SANT Domain‐Containing Scaffolding Protein 1 Regulates Differentiation and Maturation of Cardiomyocytes Derived From Human‐Induced Pluripotent Stem Cells
per: Yu‐An Lu, et al.
Publicat: (2024-07-01)

Genetic and Pharmacological YAP Activation Induces Proliferation and Improves Survival in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
per: Thuy Anh Bui, et al.
Publicat: (2023-08-01)

Recent advances in regulating the proliferation or maturation of human-induced pluripotent stem cell-derived cardiomyocytes
per: Hao Yang, et al.
Publicat: (2023-08-01)

Generation of an Alagille syndrome (ALGS) patient-derived induced pluripotent stem cell line (TRNDi032-A) carrying a heterozygous mutation (p.Cys682Leufs*7) in the JAG1 gene
per: Omer Hatim, et al.
Publicat: (2023-12-01)

Alzheimer’s in a dish – induced pluripotent stem cell-based disease modeling
per: Sherida de Leeuw, et al.
Publicat: (2019-07-01)

Three-dimensional cardiac organoid formation accelerates the functional maturation of human induced pluripotent stem cell-derived cardiomyocytes
per: Hanbyeol Lee, et al.
Publicat: (2022-05-01)

iPSC-Derived Cardiomyocytes as a Disease Model to Understand the Biology of Congenital Heart Defects
per: Chithra K. Pushpan, et al.
Publicat: (2024-08-01)

Impact of Neurons on Patient-Derived Cardiomyocytes Using Organ-On-A-Chip and iPSC Biotechnologies
per: Albin A. Bernardin, et al.
Publicat: (2022-11-01)

Sarcomere Disassembly and Transfection Efficiency in Proliferating Human iPSC-Derived Cardiomyocytes
per: Qianliang Yuan, et al.
Publicat: (2022-01-01)

Co-transplantation of Mesenchymal Stromal Cells and Induced Pluripotent Stem Cell-Derived Cardiomyocytes Improves Cardiac Function After Myocardial Damage
per: Klaus Neef, et al.
Publicat: (2022-01-01)

How can we use stem cell-derived cardiomyocytes to understand the involvement of energetic metabolism in alterations of cardiac function?
per: Sabine Rebs, et al.
Publicat: (2023-09-01)

Do Human iPSC-Derived Cardiomyocytes Cultured on PLA Scaffolds Induce Expression of CD28/CTLA-4 by T Lymphocytes?
per: David Sergeevichev, et al.
Publicat: (2022-01-01)

Increasing the physical size and nucleation status of human pluripotent stem cell-derived ventricular cardiomyocytes by cell fusion
per: Chi-Wing Kong, et al.
Publicat: (2017-03-01)

Three-Dimensional Poly-(ε-Caprolactone) Nanofibrous Scaffolds Promote the Maturation of Human Pluripotent Stem Cells-Induced Cardiomyocytes
per: Mingming Zhang, et al.
Publicat: (2022-08-01)

Polymerized Laminin-521: A Feasible Substrate for Expanding Induced Pluripotent Stem Cells at a Low Protein Concentration
per: Fernanda C. P. Mesquita, et al.
Publicat: (2022-12-01)

Cardiac calcium regulation in human induced pluripotent stem cell cardiomyocytes: Implications for disease modeling and maturation
per: Patrick Ernst, et al.
Publicat: (2023-01-01)

Generation of two induced pluripotent stem cell lines from patients with cardiac amyloidosis carrying heterozygous transthyretin (TTR) mutation
per: Bernardo Bonilauri, et al.
Publicat: (2023-10-01)

Single-cell RNA sequencing reveals key regulators and differentiation trajectory of iPSC-derived cardiomyocytes
per: Lu Li, et al.
Publicat: (2024-11-01)

Exosomes From Induced Pluripotent Stem Cell–Derived Cardiomyocytes Promote Autophagy for Myocardial Repair
per: Michelle R. Santoso, et al.
Publicat: (2020-03-01)